A carregar...
Inhibition of the human proteasome by imidazoline scaffolds
The proteasome has emerged as the primary target for the treatment of multiple myeloma. Unfortunately, nearly all patients develop resistance to competitive-type proteasome inhibitors, such as bortezomib. Herein, we describe the optimization of non-competitive proteasome inhibitors to yield derivati...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3844044/ https://ncbi.nlm.nih.gov/pubmed/23789888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm400235r |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|